(Q37850890)

English

Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens

scientific article published on 08 March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens (English)

1 reference

Europe PubMed Central

24 August 2017

drug interaction

0 references

author name string

Nimish Patel

1

1 reference

Europe PubMed Central

24 August 2017

Sandra Abdelsayed

2

1 reference

Europe PubMed Central

24 August 2017

Michael Veve

3

1 reference

Europe PubMed Central

24 August 2017

Christopher D Miller

4

1 reference

Europe PubMed Central

24 August 2017

language of work or name

0 references

publication date

8 March 2011

1 reference

Europe PubMed Central

24 August 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

24 August 2017

45

1 reference

Europe PubMed Central

24 August 2017

317-324

1 reference

Europe PubMed Central

24 August 2017

3

1 reference

Europe PubMed Central

24 August 2017

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Outcomes of dosage adjustments used to manage antiretroviral drug interactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Recognition of Risk for Clinically Significant Drug Interactions among HIV‐Infected Patients Receiving Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1P576

21 January 2018

Identifiers

10.1345/APH.1P576

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37850890&oldid=1750857634"